Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George R Simon

Showing results (21-30 of 77) with videos related to

Pageof 8
Sort By:
Cancers|June 26, 2026
Baseline Lymphopenia Predicts Survival in ICI-Naïve Solid Tumor Patients Receiving Immune Checkpoint Inhibitors: A Propensity-Matched Real-World Pan-Cancer AnalysisAhmed Ismail, Nina Balanchivadze, George R Simon, et al.
Frontiers in Oncology|January 25, 2024
Perspective: rethinking therapeutic strategies in oncologyEdward F Patz, Elizabeth B Gottlin, George R Simon
Biomolecules|May 27, 2026
Antibody-Drug Conjugates Beyond HER2 in Non-Small Cell Lung Cancer (NSCLC): Mechanisms, Emerging Targets, and Future DirectionsAhmed Ismail, Aakash Desai, George R Simon, et al.
Chest|March 15, 2005
ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancerGeorge R Simon, Swati Sharma, Alan Cantor, et al.
Frontiers in Oncology|November 30, 2016
Recent Advances in Immunotherapy in Metastatic NSCLCPranshu Bansal, Diaa Osman, Gregory N Gan, et al.
Frontiers in Oncology|May 21, 2016
Recent Advances in Targetable Therapeutics in Metastatic Non-Squamous NSCLCPranshu Bansal, Diaa Osman, Gregory N Gan, et al.
Chest|August 11, 2004
Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lungLuke T Nordquist, George R Simon, Alan Cantor, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 24, 2010
Summary of presentations from the 46th Annual Meeting of the American Society of Clinical Oncology: focus on non-small cell lung cancer (2010)Thomas E Stinchcombe, Maria Q Baggstrom, Neeta Somaiah, et al.
The International Journal of Biological Markers|January 16, 2015
Lung adenocarcinoma with concurrent KRAS mutation and ALK rearrangement responding to crizotinib: case reportSaul Campos-Gomez, Humberto Lara-Guerra, Mark J Routbort, et al.
Clinical Lung Cancer|December 28, 2016
Utilization Patterns and Trends in Epidermal Growth Factor Receptor (EGFR) Mutation Testing Among Patients With Newly Diagnosed Metastatic Lung CancerChan Shen, Kenneth L Kehl, Bo Zhao, et al.
Pageof 8

Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
Cancers|June 26, 2026
Baseline Lymphopenia Predicts Survival in ICI-Naïve Solid Tumor Patients Receiving Immune Checkpoint Inhibitors: A Propensity-Matched Real-World Pan-Cancer AnalysisAhmed Ismail, Nina Balanchivadze, George R Simon, et al.
Frontiers in Oncology|January 25, 2024
Perspective: rethinking therapeutic strategies in oncologyEdward F Patz, Elizabeth B Gottlin, George R Simon
Biomolecules|May 27, 2026
Antibody-Drug Conjugates Beyond HER2 in Non-Small Cell Lung Cancer (NSCLC): Mechanisms, Emerging Targets, and Future DirectionsAhmed Ismail, Aakash Desai, George R Simon, et al.
Chest|March 15, 2005
ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancerGeorge R Simon, Swati Sharma, Alan Cantor, et al.
Frontiers in Oncology|November 30, 2016
Recent Advances in Immunotherapy in Metastatic NSCLCPranshu Bansal, Diaa Osman, Gregory N Gan, et al.
Frontiers in Oncology|May 21, 2016
Recent Advances in Targetable Therapeutics in Metastatic Non-Squamous NSCLCPranshu Bansal, Diaa Osman, Gregory N Gan, et al.
Chest|August 11, 2004
Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lungLuke T Nordquist, George R Simon, Alan Cantor, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 24, 2010
Summary of presentations from the 46th Annual Meeting of the American Society of Clinical Oncology: focus on non-small cell lung cancer (2010)Thomas E Stinchcombe, Maria Q Baggstrom, Neeta Somaiah, et al.
The International Journal of Biological Markers|January 16, 2015
Lung adenocarcinoma with concurrent KRAS mutation and ALK rearrangement responding to crizotinib: case reportSaul Campos-Gomez, Humberto Lara-Guerra, Mark J Routbort, et al.
Clinical Lung Cancer|December 28, 2016
Utilization Patterns and Trends in Epidermal Growth Factor Receptor (EGFR) Mutation Testing Among Patients With Newly Diagnosed Metastatic Lung CancerChan Shen, Kenneth L Kehl, Bo Zhao, et al.
Pageof 8